MiR-124 suppresses cell proliferation in hepatocellular carcinoma by targeting PIK3CA

被引:150
|
作者
Lang, Qingbo [1 ]
Ling, Changquan [1 ]
机构
[1] Second Mil Med Univ, Changhai Hosp, Dept Tradit Chinese Med, Shanghai 200433, Peoples R China
关键词
MiR-124; PIK3CA; Hepatocellular carcinoma; Proliferation; CERVICAL-CANCER; LIVER-CANCER; MICRORNAS; TUMORIGENICITY; TRANSCRIPTION; METASTASIS; EXPRESSION;
D O I
10.1016/j.bbrc.2012.08.075
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
MicroRNAs (miRNAs) have crucial roles in the development and progression of human cancers, including hepatocellular carcinoma (HCC). Recent studies have shown that microRNA-124 (miR-124) was downregulated in HCC: however, the underlying mechanisms by which miR-124 suppresses tumorigenesis in HCC are largely unknown. In this study, we report that phosphoinositide 3-kinase catalytic subunit alpha (PIK3CA) is a novel target of miR-124 in HepG2 cells. Overexpression of miR-124 resulted in decreased expression of PIK3CA at both mRNA and protein levels. We found that miR-124 overexpression markedly suppressed cell proliferation by inducing G1-phase cell-cycle arrest in vitro. Consistent with the restoring miR-124 expression, PIK3CA knockdown suppressed cell proliferation, whereas overexpression of PIK3CA abolished the suppressive effect of miR-124. Mechanistic studies showed that miR-124-mediated reduction of PIK3CA resulted in suppression of PI3K/Akt pathway. The expressions of Akt and mTOR, key components of the PI3K/Akt pathway, were all downregulated. Moreover, we found over-expressed miR-124 effectively repressed tumor growth in xenograft animal experiments. Taken together, our results demonstrate that miR-124 functions as a growth-suppressive miRNA and plays an important role in inhibiting the tumorigenesis through targeting PIK3CA. (C) 2012 Elsevier Inc. All rights reserved.
引用
收藏
页码:247 / 252
页数:6
相关论文
共 50 条
  • [21] PIK3CA mutations in cutaneous squamous cell carcinoma
    Kusaba, Yudo
    Kajihara, Ikko
    Sakamoto, Ryoko
    Maeda-Otsuka, Saki
    -Kanazawa, Saori Yamada
    Sawamura, Soichiro
    Makino, Katsunari
    Aoi, Jun
    Masuguchi, Shinichi
    Fukushima, Satoshi
    INTRACTABLE & RARE DISEASES RESEARCH, 2023, 12 (03) : 206 - 207
  • [22] PIK3CA mutations in oral squamous cell carcinoma
    Kozaki, Ken-Ichi
    Suzuki, Emina
    Pimkhaokham, Atiphan
    Imoto, Issei
    Inazawa, Johji
    CANCER RESEARCH, 2006, 66 (08)
  • [23] CROSSTALK BETWEEN MIR-124 AND MEG3 REGULATES CELL PROLIFERATION AND METASTASIS OF RENAL CELL CARCINOMA
    Tang, Kun
    Zhou, Hui
    Liu, Haoran
    Ye, Tao
    Xu, Hua
    Ye, Zhangqun
    JOURNAL OF UROLOGY, 2018, 199 (04): : E1201 - E1202
  • [24] MiR-124 suppresses cell motility and adhesion by targeting talin 1 in prostate cancer cells
    Wei Zhang
    Ye-qing Mao
    Hua Wang
    Wen-juan Yin
    Shao-xing Zhu
    Wei-cheng Wang
    Cancer Cell International, 15
  • [25] MiR-124 suppresses cell motility and adhesion by targeting talin 1 in prostate cancer cells
    Zhang, Wei
    Mao, Ye-qing
    Wang, Hua
    Yin, Wen-juan
    Zhu, Shao-xing
    Wang, Wei-cheng
    CANCER CELL INTERNATIONAL, 2015, 15
  • [26] miR-124 suppresses proliferation and invasion of nasopharyngeal carcinoma cells through the Wnt/β-catenin signaling pathway by targeting Capn4
    Hu, Haili
    Wang, Guanghui
    Li, Congying
    ONCOTARGETS AND THERAPY, 2017, 10 : 2711 - 2720
  • [27] Absence of PIK3CA hotspot mutations in hepatocellular carcinoma in Japanese patients
    Y Tanaka
    F Kanai
    M Tada
    Y Asaoka
    B Guleng
    A Jazag
    M Ohta
    T Ikenoue
    K Tateishi
    S Obi
    T Kawabe
    O Yokosuka
    M Omata
    Oncogene, 2006, 25 : 2950 - 2952
  • [28] Absence of PIK3CA hotspot mutations in hepatocellular carcinoma in Japanese patients
    Tanaka, Yasuo
    Kanai, Fumihiko
    Tada, Motohisa
    Asaoka, Yoshinari
    Guleng, Bayasi
    Jazag, Amarsanaa
    Ohta, Miki
    Ikenoue, Tsuneo
    Tateishi, Keisuke
    Obi, Shuntaro
    Kawabe, Takao
    Yokosuka, Osamu
    Omata, Masao
    CANCER RESEARCH, 2006, 66 (08)
  • [29] Absence of PIK3CA hotspot mutations in hepatocellular carcinoma in Japanese patients
    Tanaka, Y.
    Kanai, F.
    Tada, M.
    Asaoka, Y.
    Guleng, B.
    Jazag, A.
    Ohta, M.
    Ikenoue, T.
    Tateishi, K.
    Obi, S.
    Kawabe, T.
    Yokosuka, O.
    Omata, M.
    ONCOGENE, 2006, 25 (20) : 2950 - 2952
  • [30] Circ-ZEB1 promotes PIK3CA expression by silencing miR-199a-3p and affects the proliferation and apoptosis of hepatocellular carcinoma
    Liu, Weiwei
    Zheng, Lu
    Zhang, Rongguiyi
    Hou, Ping
    Wang, Jiakun
    Wu, Linquan
    Li, Jing
    MOLECULAR CANCER, 2022, 21 (01)